Table 1.

Criteria for prioritisation of CTC requests for 2WW colorectal cancer referrals during the COVID-19 recovery period

FIT resultBlood results of: Ferritin <25 or>350 ug ml−1 or Haemoglobin <130 (male) or <120 (female) g/L or Platelets > 400×109  l−1Priority
>100–149.9 µg Hb/gIgnoreASAP
>20–99.9 µg Hb/g&Abnormal1
>4–20 µg Hb/gAbnormal2
>20–99.9 µg Hb/gNormal3
>4–20 µg Hb/gNormalDischarge back to referrer
FIT resultBlood results of: Ferritin <25 or>350 ug ml−1 or Haemoglobin <130 (male) or <120 (female) g/L or Platelets > 400×109  l−1Priority
>100–149.9 µg Hb/gIgnoreASAP
>20–99.9 µg Hb/g&Abnormal1
>4–20 µg Hb/gAbnormal2
>20–99.9 µg Hb/gNormal3
>4–20 µg Hb/gNormalDischarge back to referrer

CTC, CT colonography; FIT, faecal-immunochemical test; 2WW, 2-week wait.

Table 1.

Criteria for prioritisation of CTC requests for 2WW colorectal cancer referrals during the COVID-19 recovery period

FIT resultBlood results of: Ferritin <25 or>350 ug ml−1 or Haemoglobin <130 (male) or <120 (female) g/L or Platelets > 400×109  l−1Priority
>100–149.9 µg Hb/gIgnoreASAP
>20–99.9 µg Hb/g&Abnormal1
>4–20 µg Hb/gAbnormal2
>20–99.9 µg Hb/gNormal3
>4–20 µg Hb/gNormalDischarge back to referrer
FIT resultBlood results of: Ferritin <25 or>350 ug ml−1 or Haemoglobin <130 (male) or <120 (female) g/L or Platelets > 400×109  l−1Priority
>100–149.9 µg Hb/gIgnoreASAP
>20–99.9 µg Hb/g&Abnormal1
>4–20 µg Hb/gAbnormal2
>20–99.9 µg Hb/gNormal3
>4–20 µg Hb/gNormalDischarge back to referrer

CTC, CT colonography; FIT, faecal-immunochemical test; 2WW, 2-week wait.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close